FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079341705> ?p ?o ?g. }

• W2079341705 endingPage "826" @default.
• W2079341705 startingPage "819" @default.
• W2079341705 abstract "Neutrophil (PMN) activation is critical in inflammation and reperfusion injury, suggesting that PMN-directed therapies may be of clinical use. Here, leukotriene B4 (LTB4)-induced PMN influx in ear skin was equivalent between 5-lipoxygenase knockout and wild-type mice. To explore actions of lipoxin (LX) in PMN-mediated tissue injury, we prepared several novel LX stable analogues, including analogues of LXA4 and aspirin-triggered 15-epi-LXA4 as well as LXB4, and examined their impact in PMN infiltration and vascular permeability. Each applied topically to mouse ears inhibited dramatically PMN-mediated increases in vascular permeability (IC50 range of 13-26 nmol) with a rank order of 15(R/S)-methyl-LXA4 > 16-para-fluoro-phenoxy-LXA4 approximately 5(S)-methyl-LXB4 >/= 16-phenoxy-LXA4 > 5(R)-methyl-LXB4. These LX mimetics were as potent as an LTB4 receptor antagonist, yet results from microphysiometry with mouse leukocytes indicated that they do not act as LTB4 receptor level antagonists. In addition, within 24 h of delivery, > 90% were cleared from ear biopsies. Neither IL-8, FMLP, C5a, LTD4, nor platelet-activating factor act topically to promote PMN influx. When applied with LTB4, PGE2 enhanced sharply both infiltration and vascular permeability, which were inhibited by a fluorinated stable analogue of aspirin-triggered LX. These results indicate that mimetics of LXs and aspirin-triggered 15-epi-LXA4 are topically active in this model and are potent inhibitors of both PMN infiltration and PMN-mediated vascular injury." @default.
• W2079341705 created "2016-06-24" @default.
• W2079341705 creator A5029525374 @default.
• W2079341705 creator A5057221073 @default.
• W2079341705 creator A5057779986 @default.
• W2079341705 creator A5068549832 @default.
• W2079341705 creator A5089915907 @default.
• W2079341705 date "1998-02-15" @default.
• W2079341705 modified "2023-10-14" @default.
• W2079341705 title "Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues." @default.
• W2079341705 cites W1532844137 @default.
• W2079341705 cites W1601002338 @default.
• W2079341705 cites W1986483382 @default.
• W2079341705 cites W2033729972 @default.
• W2079341705 cites W2036213823 @default.
• W2079341705 cites W2056570539 @default.
• W2079341705 cites W2056759448 @default.
• W2079341705 cites W2059429399 @default.
• W2079341705 cites W2065376096 @default.
• W2079341705 cites W2162382352 @default.
• W2079341705 cites W2260834837 @default.
• W2079341705 cites W2409834598 @default.
• W2079341705 cites W2443199170 @default.
• W2079341705 doi "https://doi.org/10.1172/jci1578" @default.
• W2079341705 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/508630" @default.
• W2079341705 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9466977" @default.
• W2079341705 hasPublicationYear "1998" @default.
• W2079341705 type Work @default.
• W2079341705 sameAs 2079341705 @default.
• W2079341705 citedByCount "221" @default.
• W2079341705 countsByYear W20793417052012 @default.
• W2079341705 countsByYear W20793417052013 @default.
• W2079341705 countsByYear W20793417052014 @default.
• W2079341705 countsByYear W20793417052015 @default.
• W2079341705 countsByYear W20793417052016 @default.
• W2079341705 countsByYear W20793417052017 @default.
• W2079341705 countsByYear W20793417052018 @default.
• W2079341705 countsByYear W20793417052019 @default.
• W2079341705 countsByYear W20793417052020 @default.
• W2079341705 countsByYear W20793417052021 @default.
• W2079341705 countsByYear W20793417052022 @default.
• W2079341705 countsByYear W20793417052023 @default.
• W2079341705 crossrefType "journal-article" @default.
• W2079341705 hasAuthorship W2079341705A5029525374 @default.
• W2079341705 hasAuthorship W2079341705A5057221073 @default.
• W2079341705 hasAuthorship W2079341705A5057779986 @default.
• W2079341705 hasAuthorship W2079341705A5068549832 @default.
• W2079341705 hasAuthorship W2079341705A5089915907 @default.
• W2079341705 hasBestOaLocation W20793417051 @default.
• W2079341705 hasConcept C113045295 @default.
• W2079341705 hasConcept C121332964 @default.
• W2079341705 hasConcept C126322002 @default.
• W2079341705 hasConcept C153400128 @default.
• W2079341705 hasConcept C170493617 @default.
• W2079341705 hasConcept C180899940 @default.
• W2079341705 hasConcept C181199279 @default.
• W2079341705 hasConcept C185592680 @default.
• W2079341705 hasConcept C203014093 @default.
• W2079341705 hasConcept C2776042228 @default.
• W2079341705 hasConcept C2776352991 @default.
• W2079341705 hasConcept C2776452501 @default.
• W2079341705 hasConcept C2776685179 @default.
• W2079341705 hasConcept C2776885963 @default.
• W2079341705 hasConcept C2776914184 @default.
• W2079341705 hasConcept C2777628954 @default.
• W2079341705 hasConcept C2778078955 @default.
• W2079341705 hasConcept C2780415110 @default.
• W2079341705 hasConcept C55493867 @default.
• W2079341705 hasConcept C71924100 @default.
• W2079341705 hasConcept C97355855 @default.
• W2079341705 hasConcept C98274493 @default.
• W2079341705 hasConceptScore W2079341705C113045295 @default.
• W2079341705 hasConceptScore W2079341705C121332964 @default.
• W2079341705 hasConceptScore W2079341705C126322002 @default.
• W2079341705 hasConceptScore W2079341705C153400128 @default.
• W2079341705 hasConceptScore W2079341705C170493617 @default.
• W2079341705 hasConceptScore W2079341705C180899940 @default.
• W2079341705 hasConceptScore W2079341705C181199279 @default.
• W2079341705 hasConceptScore W2079341705C185592680 @default.
• W2079341705 hasConceptScore W2079341705C203014093 @default.
• W2079341705 hasConceptScore W2079341705C2776042228 @default.
• W2079341705 hasConceptScore W2079341705C2776352991 @default.
• W2079341705 hasConceptScore W2079341705C2776452501 @default.
• W2079341705 hasConceptScore W2079341705C2776685179 @default.
• W2079341705 hasConceptScore W2079341705C2776885963 @default.
• W2079341705 hasConceptScore W2079341705C2776914184 @default.
• W2079341705 hasConceptScore W2079341705C2777628954 @default.
• W2079341705 hasConceptScore W2079341705C2778078955 @default.
• W2079341705 hasConceptScore W2079341705C2780415110 @default.
• W2079341705 hasConceptScore W2079341705C55493867 @default.
• W2079341705 hasConceptScore W2079341705C71924100 @default.
• W2079341705 hasConceptScore W2079341705C97355855 @default.
• W2079341705 hasConceptScore W2079341705C98274493 @default.
• W2079341705 hasIssue "4" @default.
• W2079341705 hasLocation W20793417051 @default.
• W2079341705 hasLocation W20793417052 @default.
• W2079341705 hasLocation W20793417053 @default.
• W2079341705 hasLocation W20793417054 @default.

• next